查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2010032

医用塑胶市场：2026-2032年全球市场预测（按产品类型、材料、製造流程、应用和最终用户划分）

Medical Plastics Market by Product, Material Type, Process Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，医用塑胶市场价值将达到 398.2 亿美元，到 2026 年将成长至 434.3 亿美元，到 2032 年将达到 766.7 亿美元，复合年增长率为 9.81%。

主要市场统计数据
基准年 2025 398.2亿美元
预计年份：2026年 434.3亿美元
预测年份 2032 766.7亿美元
复合年增长率 (%) 9.81%

对医用塑胶市场进行简要概述，重点介绍需要经营团队关注的技术、监管和供应链转折点。

医用塑胶市场正处于关键转折点，快速的技术进步、日益严格的监管以及不断变化的供应链动态共同塑造了这个市场。新材料的创新、精密製造技术的进步以及对一次性产品安全性的重新关注，共同为製造商、供应商和医疗机构带来了机会和挑战。相关人员正在重新评估产品的可靠性、生物相容性和灭菌适用性，同时也寻求经济有效的途径来维持供应的连续性和合规性。

材料创新、精密製造、监管压力和供应链重组如何重新定义医用塑胶製造商的策略重点。

医用塑胶产业正经历一系列变革，这些变革正在全面重塑竞争动态和业务重点。首先，小型化和功能整合化的发展趋势正在加速精密射出成型和微流体组件的应用，迫使製造商投资高精度模具和品管系统。同时，聚合物配方也朝着兼顾耐灭菌性和降低萃取率及洗脱率的方向发展，使得材料选择策略与最终用途检验週期更加紧密地结合。

由于关税政策的变化导致采购复杂化、供应风险增加以及生产系统重组，各公司正在采取策略应对措施和营运调整。

美国2025年实施的新关税体系将引入复杂的政策因素，影响整个价值链的采购决策、供应商谈判立场和产品成本结构。虽然关税主要影响进口树脂、零件和成品组件，但其间接影响也将波及物流规划、库存策略和长期供应商关係。製造商和采购负责人正在重新评估关税风险，具体措施包括：绘製材料清单（BOM）敏感性图，寻找关税豁免机会，并透过比较供应商转移成本与关税负担承担情况来评估净收益。

透过多维细分整合分析，确定如何调整产品设计方案、材料选择和製程能力，以满足多样化的临床和商业性需求。

基于细分市场的洞察揭示了应用、产品、材料、工艺和最终用户等维度上的差异化机会和风险概况。从应用观点来看，市场涵盖诊断、一次性产品和耗材、植入、医疗设备和医疗包装，每种产品都有其独特的技术和监管限制。在一次性产品和耗材方面，导管和管材需要高柔韧性和生物相容性；手套和手术铺巾优先考虑阻隔性和触感回馈；针头和套管需要精确的表面光洁度和抗疲劳性；注射器和药筒则依赖于尺寸稳定性和密封性。诊断和监测设备优先考虑低萃取率和光学透明度，而外科和治疗设备通常需要特殊的聚合物混合物和可追溯性系统。

区域製造能力、管理体制和医疗保健采购实践如何影响全球市场的战术性采购和合规策略？

美洲、欧洲、中东和非洲以及亚太地区的製造能力、法规结构和医疗保健采购实践差异显着，因此区域趋势仍然是策略规划的核心。在美洲，成熟的供应链、强大的流程专业知识基础以及大规模医院网路带来的集中需求，创造了有利于大规模生产和建立成熟的供应商伙伴关係的环境。在该地区营运的公司越来越注重整合品质系统和物流弹性，同时也考虑近岸外包以降低运输风险。

在医疗塑胶领域，基于能力的差异化，包括精密製造、协作材料开发和供应链管治，决定了竞争优势。

医疗塑胶产业的主要企业正透过在精密製造、材料科学和法规遵循基础设施方面的定向投资来凸显自身优势。一些製造商优先发展微型组件製造能力和先进成型技术，以抓住诊断设备和微创治疗领域不断增长的市场机会；而另一些製造商则专注于薄膜、片材和包装的创新，以满足不断变化的灭菌和阻隔性能要求。聚合物混配商和组件製造商之间的策略伙伴关係日益普遍，从而能够共同开发针对特定加工条件和灭菌方法优化的树脂等级。

在医用塑胶领域，製造商和买家可以立即采取哪些实际有效的措施来增强韧性、加快产品开发并减少监管摩擦？

行业领导者应采取积极主动的方式，将洞察转化为可持续的竞争优势。首先，优先投资于材料特性分析和灭菌验证，以缩短设备整合上市时间，并减少下游流程的监管阻力。其次，建构能够处理微尺度射出成型和二次组装的柔性製造单元，以支援结合可重复使用和一次性组件的混合产品架构。第三，建构多层次的供应商生态系统，包括关键树脂和组件的认证二级讯息，并制定正式的应急库存策略，以降低贸易中断和关税相关成本波动带来的风险。

我们透明、多方面的研究框架，结合了专家访谈、技术标准审查和供应链压力测试，提供了与决策直接相关的见解。

本分析采用多面向研究途径，结合对第一线专家的访谈、技术文献综述和跨产业流程评估，从中提炼出切实可行的见解。关键资讯包括与供应链经理、产品工程师和法规专家进行的结构化讨论，从而获得关于流程限制、材料性能权衡和区域采购趋势的定性见解。此外，还仔细审查了技术文献和标准指南，以确保材料声明符合当前的灭菌和生物相容性要求，并检验了挤出、注塑、射出成型、热成型和吹塑成型製造等工艺的工艺能力表征。

将策略重点和能力要求整合起来，显示公司应该如何协调其工程、监管和采购决策，以实现可持续的韧性。

简而言之，在材料创新、对製造精度要求、监管趋严以及贸易政策演变的驱动下，医用塑胶产业正经历重大的结构调整。在这种环境下取得成功，需要整合材料科学和工艺能力，加强供应商管治，并采取灵活的製造和筹资策略，以应对政策衝击并维持产品品质。投资可灭菌聚合物、微成型技术和数位化可追溯性的公司，将更有能力满足医院、门诊中心、检查室和製药厂商的多样化需求。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 医用塑胶市场：依产品分类

  • 吹塑成型件
  • 薄膜
  • 射出成型零件
    • 连接器和配件
    • 外壳和外罩
    • 微流体组件
  • 管子

第九章 医用塑胶市场：依材料类型划分

  • 聚碳酸酯
  • 聚乙烯
  • 聚丙烯
  • 聚氯乙烯
  • 硅酮

第十章：依製造流程分類的医用塑胶市场

  • 增材製造
  • 吹塑成型
  • 挤压
  • 射出成型
  • 热成型

第十一章 医用塑胶市场：依应用领域划分

  • 诊断
  • 一次产品和耗材
    • 导尿管
    • 手套和帷幔
    • 针头和套管
    • 注射器和药筒
  • 植入
  • 医疗设备
    • 诊断设备
    • 监控设备
    • 手术器械
    • 治疗设备
  • 医疗包装

第十二章 医用塑胶市场：依最终用户划分

  • 门诊手术中心
  • 居家医疗
  • 医院
  • 检查室
  • 製药公司

第十三章 医用塑胶市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 医用塑胶市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 医用塑胶市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国医用塑胶市场

第十七章：中国医用塑胶市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • BASF SE
  • Celanese Corporation
  • Covestro AG
  • Dow Inc.
  • DuPont de Nemours, Inc.
  • Eastman Chemical Company
  • Ensinger GmbH
  • Evonik Industries AG
  • Gerresheimer AG
  • Minnesota Rubber & Plastics, Inc.
  • Mitsubishi Chemical Corporation
  • Nolato AB
  • RAUMEDIC AG
  • RTP Company
  • Rochling SE & Co. KG
  • Saudi Basic Industries Corporation
  • Sekisui Chemical Co., Ltd.
  • Solvay SA
  • Teknor Apex Company
  • Westlake Chemical Corporation
Product Code: MRR-434CCDA04ECE

The Medical Plastics Market was valued at USD 39.82 billion in 2025 and is projected to grow to USD 43.43 billion in 2026, with a CAGR of 9.81%, reaching USD 76.67 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 39.82 billion
Estimated Year [2026] USD 43.43 billion
Forecast Year [2032] USD 76.67 billion
CAGR (%) 9.81%

A concise orienting overview of the medical plastics landscape that highlights technological, regulatory, and supply chain inflection points demanding executive attention

The market for medical-grade plastics is at a pivotal juncture shaped by rapid technological progress, heightened regulatory scrutiny, and shifting supply chain dynamics. Emerging material innovations, advances in precision manufacturing, and a renewed focus on single-use safety profiles have converged to create both risk and opportunity for manufacturers, suppliers, and healthcare providers. Stakeholders are recalibrating around product reliability, biocompatibility, and sterilization compatibility while seeking cost-effective pathways to sustain supply continuity and regulatory compliance.

This executive summary synthesizes key developments across applications, products, materials, processes, end users, and geographies to provide a coherent view of near-term strategic imperatives. It integrates observed changes in adoption patterns among hospitals, outpatient centers, laboratories, and pharmaceutical manufacturers, and places those behaviors in the context of manufacturing choices such as injection molding, extrusion, and additive manufacturing. The goal is to equip leaders with a clear, actionable understanding of where to allocate engineering effort, how to reconfigure supply relationships, and what regulatory and tariff-driven headwinds to anticipate, all while preserving product safety and performance fidelity.

How material innovation, precision manufacturing, regulatory pressure, and supply chain reconfiguration are collectively redefining strategic priorities for medical plastics manufacturers

The landscape for medical plastics is evolving through several transformative shifts that collectively reshape competitive dynamics and operational priorities. First, the push for miniaturization and functional integration is accelerating adoption of precision injection molded components and microfluidic parts, compelling manufacturers to invest in higher tolerance tooling and quality systems. At the same time, there is a parallel migration toward polymer formulations that balance sterilization resistance with reduced extractables and leachables, driving material selection strategies closer to end-use validation cycles.

Simultaneously, the interplay between single-use disposables and reusable device components is creating hybrid product architectures that require novel joining and sterilization approaches. Supply chain resilience is another defining vector: companies are diversifying supplier bases, qualifying alternate resin sources, and increasing onshoring or nearshoring of critical components to mitigate logistics bottlenecks and geopolitical risk. Finally, increased regulatory emphasis on device traceability and sustainability considerations is prompting investments in manufacturing data capture and recyclable polymer pathways. Together these shifts demand cross-functional responses that align material science, process engineering, and regulatory affairs toward faster, safer, and more adaptable product lifecycles.

Strategic responses and operational adjustments companies are adopting as tariff policy shifts create procurement complexity, supply risk, and incentives for production realignment

The introduction of newly calibrated tariffs in the United States in 2025 presents a complex policy overlay that influences sourcing decisions, supplier negotiation posture, and product cost structures across the value chain. While tariffs primarily affect imported resins, components, and finished assemblies, the indirect consequences extend to logistics planning, inventory strategies, and long-term supplier relationships. Manufacturers and purchasers are reassessing tariff exposure by mapping bill-of-materials sensitivity, identifying tariff-exempt classification opportunities, and evaluating the net benefit of supplier relocation versus tariff absorption.

In practice, tariff-driven cost pressures are accelerating conversations about vertical integration and nearshoring of critical production steps, particularly for high-value injection molded components and specialized tubing assemblies that are core to device performance. Procurement teams are also intensifying compliance and customs classification efforts to avoid inadvertent misclassification and to take advantage of any available preferential trade treatments. From an operational perspective, companies are prioritizing multi-sourcing arrangements, establishing contingency inventory buffers for time-sensitive disposables, and pursing contractual mechanisms to share tariff risk with partners. These strategic responses aim to preserve continuity of care and product availability while maintaining acceptable margin profiles under the new trade conditions.

A cross-dimensional segmentation synthesis revealing where product design choices, material selection, and process capabilities must align to meet diverse clinical and commercial requirements

Segmentation-driven insight reveals differentiated opportunities and risk profiles across application, product, material, process, and end-user dimensions. When viewing the market through the lens of application, diagnostics, disposables and consumables, implants, medical devices, and medical packaging each exhibit distinct engineering and regulatory constraints. Within disposables and consumables, catheters and tubing demand high flexural performance and biocompatibility, gloves and drapes prioritize barrier properties and tactile responsiveness, needles and cannulas require precise surface finish and fatigue resistance, and syringes and cartridges depend on dimensional stability and seal integrity. Diagnostic and monitoring devices emphasize low extractables and optical clarity, whereas surgical and therapeutic devices often necessitate specialized polymer blends and traceability systems.

Examining products, blow molded components, films and sheets, injection molded components, and tubing form the backbone of device construction. Injection molded components in particular-encompassing connectors and fittings, housings and casings, and microfluidic components-require exacting tolerances, validated molding cycles, and robust cleanroom integration, making supplier qualification rigorously technical. Material selection acts as a fundamental differentiator: polycarbonate is prized for optical clarity and impact resistance; polyethylene and polypropylene are valued for chemical inertness and cost-efficiency; polyvinyl chloride balances flexibility with processability; and silicone provides exceptional biocompatibility and thermal resilience. Each polymer family brings trade-offs in sterilization compatibility, extraction behavior, and long-term stability that must be reconciled with device function.

Process-type segmentation highlights the growing role of additive manufacturing for low-volume, high-complexity parts and the continuing primacy of blow molding, extrusion, injection molding, and thermoforming for higher-volume components. Additive approaches enable rapid iteration and tooling-free customization but require downstream validation for medical use, while conventional molding processes deliver consistent throughput and established qualification paths. Finally, end-user segmentation-spanning ambulatory surgery centers, home healthcare, hospitals, laboratories, and pharmaceutical manufacturers-drives design priorities and service-level expectations. Devices intended for home healthcare must prioritize ease of use and transportability, whereas hospital and laboratory applications often impose stricter sterilization, traceability, and compatibility requirements. Integrating these segmentation axes enables a granular assessment of where to invest in materials engineering, process capabilities, and supplier partnerships to meet differentiated clinical and commercial needs.

How regional manufacturing capabilities, regulatory regimes, and healthcare procurement behaviors are shaping tactical sourcing and compliance strategies across global markets

Regional dynamics remain central to strategic planning, as manufacturing capacity, regulatory frameworks, and healthcare procurement behaviors vary significantly across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, established supply chains, a strong base of process expertise, and concentrated demand from large hospital networks create an environment conducive to high-volume production and advanced supplier partnerships. Companies operating here increasingly focus on quality system integration and logistical resilience, while exploring nearshoring to reduce transit risk.

Across Europe, Middle East & Africa, regulatory harmonization, stringent biocompatibility standards, and progressive sustainability mandates influence material choices and product end-of-life strategies. Suppliers in this region often lead in recyclable polymer initiatives and in implementing comprehensive environmental management systems. Contrastingly, Asia-Pacific remains a hub for high-volume polymer processing capacity and rapid scaling, supported by extensive supplier ecosystems for raw resins, components, and aftermarket services. Market participants leveraging Asia-Pacific manufacturing must balance cost advantages with rigorous oversight on quality assurance and supplier qualification to ensure consistent compliance. Cross-region collaboration, including diversified sourcing and region-specific validation pathways, is therefore emerging as a best practice to reconcile cost, compliance, and continuity considerations.

Why capability-based differentiation in precision manufacturing, materials co-development, and supply chain governance determines competitive edge in medical plastics

Leading companies in the medical plastics ecosystem are distinguishing themselves through targeted investment in precision manufacturing, material science, and regulatory compliance infrastructures. Some manufacturers are prioritizing micro-component capabilities and advanced molding to capture growth in diagnostic devices and minimally invasive therapies, while others are doubling down on films, sheets, and packaging innovations to meet evolving sterilization and barrier performance requirements. Strategic partnerships between polymer formulators and component manufacturers are becoming more common, enabling co-development of resin grades optimized for specific processing windows and sterilization methods.

Organizational differentiation also stems from supply chain governance practices. Top-performing firms maintain rigorous supplier qualification programs, digital traceability systems, and contingency sourcing playbooks that reduce risk during disruptions. Investment in testing labs and biocompatibility expertise supports faster regulatory submissions and smoother audits. In addition, several companies are exploring modular manufacturing footprints that combine localized final assembly with distributed component fabrication to improve responsiveness to regional demand swings. Collectively, these company-level moves underscore a shift from commodity competition toward capability-based differentiation anchored in engineering depth, regulatory readiness, and resilient supply networks.

Practical, high-impact actions manufacturers and purchasers can take immediately to strengthen resilience, speed product development, and reduce regulatory friction in medical plastics

Industry leaders should take a proactive approach to translate insight into durable advantage. First, prioritize investments in materials characterization and sterilization validation to shorten time-to-market for device integrations and to reduce downstream regulatory friction. Second, build flexible manufacturing cells capable of handling both micro-scale injection molding and secondary assembly to support hybrid product architectures that combine reusable and single-use elements. Third, establish multi-tier supplier ecosystems that include qualified secondary sources for critical resins and components alongside formal contingency inventory strategies to mitigate trade disruptions and tariff-related cost volatility.

Additionally, embed digital traceability and quality analytics across production workflows to enable real-time decision making, faster corrective actions, and stronger audit readiness. Pursue strategic collaborations with polymer specialists to co-develop resin formulations that minimize extractables while preserving processability, and align those efforts with sustainability roadmaps that explore recyclable or lower-carbon polymer options where feasible. Finally, align commercial contracting with risk-sharing mechanisms that address tariff exposure and supply variability, and ensure procurement, engineering, and regulatory teams jointly own supplier qualification criteria to accelerate onboarding without compromising safety or compliance.

A transparent, multi-method research framework combining expert interviews, technical standards review, and supply chain stress testing to underpin decision-focused insights

This analysis is informed by a multi-method research approach that combines primary expert interviews, technical literature review, and cross-functional process assessment to produce actionable findings. Primary inputs included structured discussions with supply chain leaders, product engineers, and regulatory professionals who provided qualitative insights into process constraints, material performance trade-offs, and regional sourcing behaviors. Technical literature and standards guidance were reviewed to ensure material assertions align with current sterilization and biocompatibility expectations, and to verify process capability characterizations for extrusion, injection molding, blow molding, thermoforming, and additive manufacturing.

To ensure robustness, the methodology integrated comparative supplier capability mapping and scenario-based stress testing for tariff and logistics disruptions. Cross-validation steps included triangulating interview observations with documented regulatory decisions and published technical notes, and assessing reproducibility of key engineering insights across multiple industry segments. Care was taken to avoid proprietary or vendor-specific claims, and analytical emphasis was placed on operational implications and decision-relevant trade-offs rather than quantitative market estimates. This approach yields a pragmatic foundation for planning and prioritization while preserving methodological transparency and traceability.

A synthesis of strategic priorities and capability imperatives that frames how companies should align engineering, regulatory, and procurement decisions for lasting resilience

In sum, the medical plastics sector is navigating a period of significant structural recalibration driven by material innovation, manufacturing precision demands, regulatory intensification, and evolving trade policy. Success in this environment depends on integrating material science with process capabilities, bolstering supplier governance, and adopting flexible manufacturing and sourcing strategies that can absorb policy shocks and sustain product quality. Companies that invest in sterilization-compatible polymers, micro-molding expertise, and digital traceability will be better positioned to meet the differentiated needs of hospitals, ambulatory centers, laboratories, and pharmaceutical manufacturers.

Looking forward, the most resilient organizations will be those that treat segmentation-driven product design, regional manufacturing strategy, and tariff risk management as interconnected components of a unified operating model. That integrated perspective enables faster innovation cycles, improved regulatory outcomes, and a more stable supply posture, all of which translate into better patient safety and more predictable commercial performance. The recommendations presented here are intended to serve as an actionable roadmap for leaders who must align engineering, regulatory, and procurement priorities under evolving market conditions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Plastics Market, by Product

  • 8.1. Blow Molded Components
  • 8.2. Films & Sheets
  • 8.3. Injection Molded Components
    • 8.3.1. Connectors & Fittings
    • 8.3.2. Housings & Casings
    • 8.3.3. Microfluidic Components
  • 8.4. Tubing

9. Medical Plastics Market, by Material Type

  • 9.1. Polycarbonate
  • 9.2. Polyethylene
  • 9.3. Polypropylene
  • 9.4. Polyvinyl Chloride
  • 9.5. Silicone

10. Medical Plastics Market, by Process Type

  • 10.1. Additive Manufacturing
  • 10.2. Blow Molding
  • 10.3. Extrusion
  • 10.4. Injection Molding
  • 10.5. Thermoforming

11. Medical Plastics Market, by Application

  • 11.1. Diagnostics
  • 11.2. Disposables & Consumables
    • 11.2.1. Catheters & Tubing
    • 11.2.2. Gloves & Drapes
    • 11.2.3. Needles & Cannulas
    • 11.2.4. Syringes & Cartridges
  • 11.3. Implants
  • 11.4. Medical Devices
    • 11.4.1. Diagnostic Devices
    • 11.4.2. Monitoring Devices
    • 11.4.3. Surgical Devices
    • 11.4.4. Therapeutic Devices
  • 11.5. Medical Packaging

12. Medical Plastics Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Home Healthcare
  • 12.3. Hospitals
  • 12.4. Laboratories
  • 12.5. Pharmaceutical Manufacturers

13. Medical Plastics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Plastics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Plastics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical Plastics Market

17. China Medical Plastics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. BASF SE
  • 18.6. Celanese Corporation
  • 18.7. Covestro AG
  • 18.8. Dow Inc.
  • 18.9. DuPont de Nemours, Inc.
  • 18.10. Eastman Chemical Company
  • 18.11. Ensinger GmbH
  • 18.12. Evonik Industries AG
  • 18.13. Gerresheimer AG
  • 18.14. Minnesota Rubber & Plastics, Inc.
  • 18.15. Mitsubishi Chemical Corporation
  • 18.16. Nolato AB
  • 18.17. RAUMEDIC AG
  • 18.18. RTP Company
  • 18.19. Rochling SE & Co. KG
  • 18.20. Saudi Basic Industries Corporation
  • 18.21. Sekisui Chemical Co., Ltd.
  • 18.22. Solvay S.A.
  • 18.23. Teknor Apex Company
  • 18.24. Westlake Chemical Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL PLASTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL PLASTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDED COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDED COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDED COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY FILMS & SHEETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY FILMS & SHEETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY FILMS & SHEETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CONNECTORS & FITTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CONNECTORS & FITTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CONNECTORS & FITTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOUSINGS & CASINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOUSINGS & CASINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOUSINGS & CASINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MICROFLUIDIC COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MICROFLUIDIC COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MICROFLUIDIC COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYCARBONATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYCARBONATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYCARBONATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY ADDITIVE MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY ADDITIVE MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY ADDITIVE MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERMOFORMING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERMOFORMING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERMOFORMING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CATHETERS & TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CATHETERS & TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CATHETERS & TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY GLOVES & DRAPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY GLOVES & DRAPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY GLOVES & DRAPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY NEEDLES & CANNULAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY NEEDLES & CANNULAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY NEEDLES & CANNULAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SYRINGES & CARTRIDGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SYRINGES & CARTRIDGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SYRINGES & CARTRIDGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. GCC MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. GCC MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 200. GCC MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 201. GCC MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. GCC MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 205. GCC MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 206. GCC MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. G7 MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. G7 MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 227. G7 MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 228. G7 MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. G7 MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. G7 MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 232. G7 MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 233. G7 MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. NATO MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. NATO MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 236. NATO MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 237. NATO MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. NATO MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. NATO MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. NATO MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 241. NATO MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. NATO MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES MEDICAL PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA MEDICAL PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)